MannKind Corporation /
scPharmaceuticals Inc.
MannKind Corporation agrees to buy scPharmaceuticals Inc.




Source for the buyer and target: MannKind Corporation
For the buyer and target.
“As previously disclosed in the Current Report on Form 8-K filed with the Securities and Exchange Commission (“ SEC ”) by MannKind Corporation, a Delaware corporation (the “ Company ”) on August 25, 2025, the Company entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), dated as of August 24, 2025, with Seacoast Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of the Company (“ Purchaser ”), and scPharmaceuticals Inc., a Delaware corporation (“ scPharma ”).”
Published 9 Oct 2025
Open the sourceWhat happened
MannKind Corporation agreed to acquire scPharmaceuticals Inc. for approximately $296.5 million, according to a filing dated Oct. 9, 2025. [01]
The source
Everything on this page comes from the source below, quoted word for word.
MannKind Corporation agrees to buy scPharmaceuticals Inc.
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“MannKind Corporation agrees to buy scPharmaceuticals Inc. MannKind Corporation agreed to acquire scPharmaceuticals Inc. for approximately $296.5 million, according to a filing dated Oct. 9, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly